Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum complement level in dogs with neoplastic disease.

B R Madewell

    American Journal of Veterinary Research
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    T-cell-derived malignant lymphoma in the boxer breed.

    Veterinary and comparative oncology·2009
    Same author

    Comparative oncology--new and expanding opportunities for research.

    Veterinary and comparative oncology·2009
    Same author

    A landmark in Veterinary and Comparative Oncology.

    Veterinary and comparative oncology·2009
    Same author

    Cyclin D3 expression in normal fetal, normal adult and neoplastic feline tissue.

    Journal of comparative pathology·2005
    Same author

    Feline vaccine-associated fibrosarcoma: morphologic distinctions.

    Veterinary pathology·2002
    Same author

    "Equine basal cell tumors: 6 cases (1985-1999)".

    Journal of veterinary internal medicine·2001
    Same journal

    Plasma formiminoglutamic acid shows potential as a functional marker of folate deficiency in cats and dogs: development and validation of a liquid chromatography-tandem mass spectrometry method.

    American journal of veterinary research·2026
    Same journal

    Spot urinary electrolytes are associated with decongestion and duration of hospitalization in dogs with acute left-sided congestive heart failure secondary to myxomatous mitral valve disease.

    American journal of veterinary research·2026
    Same journal

    Oral administration of a live-attenuated Bordetella bronchiseptica vaccine (Vanguard B Oral) induces protective immunity against challenge 7 days after vaccination in dogs.

    American journal of veterinary research·2026
    Same journal

    Inertial measurement units are comparable to motion capture for measuring intersegmental spinal angular velocities in horses.

    American journal of veterinary research·2026
    Same journal

    Intra-articular interleukin-1β induces early synovitis in an ex vivo autologously perfused equine forelimb model.

    American journal of veterinary research·2026
    Same journal

    Computed tomographic liver volumetry and hepatic attenuation in dogs with histologically confirmed cirrhosis compared with dogs without liver disease.

    American journal of veterinary research·2026
    See all related articles

    Canine cancer and systemic illness increase complement system variability. While average hemolytic complement reactivity showed no significant difference in dogs with cancer or other serious illnesses compared to healthy dogs, the spread of reactivity was significantly greater in abnormal groups.

    Area of Science:

    • Veterinary Immunology
    • Complement System Biology
    • Canine Oncology

    Background:

    • The complement system is crucial for immune responses.
    • Alterations in complement activity are observed in various diseases.
    • Understanding complement behavior in sick dogs is important for diagnostics.

    Purpose of the Study:

    • To determine the hemolytic reactivity of the complement system in dogs with cancer and other systemic illnesses.
    • To compare complement reactivity in cancerous dogs (lymphosarcoma and other neoplasms) and systemically ill dogs with healthy controls.
    • To investigate if disease affects the variability of complement reactivity.

    Main Methods:

    • Hemolytic complement reactivity was measured in serum samples from 119 dogs.
    • Dogs were categorized into four groups: healthy controls, lymphosarcoma, other malignant neoplasms, and non-neoplastic systemic illnesses.

    Related Experiment Videos

  • Variance ratio testing was used to compare the dispersion of hemolytic complement values within groups.

    • Main Results:

    • No significant differences were found in the mean hemolytic complement reactivity among the four groups.
    • However, all groups of abnormal dogs (cancerous and systemically ill) exhibited significantly greater variance in hemolytic complement values compared to normal dogs.
    • This indicates increased heterogeneity of complement activity in diseased states.

    Conclusions:

    • While the average complement activity may not change, its variability significantly increases in dogs with cancer or other serious systemic diseases.
    • This heightened variability in hemolytic complement reactivity could serve as a potential indicator of disease in canine populations.
    • Further research is warranted to explore the clinical implications of complement system dysregulation in canine pathology.